Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PEP-CMV |
Trade Name | |
Synonyms | PEP-CMV vaccine |
Drug Descriptions |
PEP-CMV is a peptide vaccine that targets the human cytomegalovirus (CMV) antigen pp65, which may induce an immune response against tumor cells (J Clin Oncol 42, 2024 (suppl 16; abstr 2039)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C107243 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Nivolumab + PEP-CMV + Temozolomide | Nivolumab PEP-CMV Temozolomide | 0 | 1 |
PEP-CMV | PEP-CMV | 0 | 0 |
PEP-CMV + Temozolomide | PEP-CMV Temozolomide | 0 | 1 |